U.S. DOJ Requires Divestiture by Mittal Steel to Preserve Competition in the Tin Mill Products Industry
Client Alert | 1 min read | 02.20.07
On Tuesday, February 20, 2007, the U.S. Department of Justice announced that it will require Mittal Steel Company N.V. to divest its Sparrows Point facility in Maryland to counteract competitive harm resulting from Mittal's recently proposed $33 billion acquisition of Arcelor S.A. According to the DOJ, Mittal's acquisition would have substantially lessened competition in the market for tin mill products in the eastern United States. Therefore, the DOJ's proposed consent decree will require Mittal to divest Dofasco Inc., a Canadian company owned by Arcelor, which the DOJ recognized may not be possible due to Arcelor's placement of legal title of Dofasco into a Dutch foundation in an attempt to defeat Mittal's hostile takeover bid. Thus, the DOJ proposed that if the sale of Dofasco cannot be carried out, then the DOJ will require Mittal to divest its Sparrows Point mill.
Insights
Client Alert | 3 min read | 06.26.25
FDA Targets Gene Editing Clinical Trials in China and other “Hostile Countries”
In a somewhat ambiguous press release on Wednesday, June 18, 2025, the Food and Drug Administration (FDA) announced a halt and “immediate review” of new clinical trials where American patients’ cells are sent to China or other “hostile countries” for genetic engineering with the expectation that the cells will be infused back into U.S. patients.[1] A subsequent podcast published by the agency also said that therapies that involved cells that were sent to China for genetic engineering and intended for subsequent infusion into U.S. patients would not be approved going forward. The announcement said that there is “mounting evidence” that some clinical researchers failed to obtain informed consent from trial participants about the international transfer and manipulation of biological material.
Client Alert | 3 min read | 06.26.25
Client Alert | 4 min read | 06.26.25
Ninth Circuit Affirms that CIPA Only Applies to Third-Party Eavesdropping
Client Alert | 4 min read | 06.24.25
CBP Issues First Comprehensive Guide to Modifying a Withhold Release Order (WRO)
